SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

Validogen is launching next-generation synthetic methanol-free promoters, which may lead to “substantially increased productivities.” ...

Boehringer Ingelheim has acquired an exclusive license for a preclinical, small molecule program from Sitryx Therapeutics.

Expands Quotient's capabilities for handling and manufacturing highly potent API (HPAPI) drug molecules and products.

Asahi Kasei has agreed to acquire all issued shares of Aicuris Anti-infective Cures AG, a German-based biopharmaceutical company.

Brainlab and Precision NeuroMed have a new strategic partnership for an artificial intelligence (AI)-enabled treatment planning platform.

How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.

Shilpa Biologicals has signed a licensing agreement with SteinCares to commercialize a biosimilar in the latter’s home region, Latin America.

Nexus Precision Health, a precision medicine technology company, has acquired Leal Health, an AI-powered patient ...

Alkermes, a global biopharmaceutical company headquartered in Ireland, is transitioning to a new Chief Executive Officer (CEO ...

Asahi Kasei Pharma has entered an exclusive global license agreement with Alchemedicine covering novel lead compounds for a ...

The FDA has granted full approval to Pfizer Inc.’s Braftovi when used with Eli Lilly’s Erbitux (cetuximab) and fluorouracil‑based chemotherapy for adults with metastatic colorectal cancer carrying a ...